General Information

Basic Resources from Various Sites:

• Hepatitis B (MedlinePlus)
• What I need to know about hepatitis B (National Institute of Diabetes and Digestive and Kidney Diseases) and Spanish version
• Hepatitis A, B & C (Avert)
• Towards a healthy liver (Project Inform) and Spanish version
• Blood Safety (CDC) – includes information about screening blood for HIV, viral hepatitis, and other disease organisms

Resources from CDC:

• Frequently Asked Questions (FAQs) for the Public
• FAQs for Health Professionals
• Hepatitis B vaccine: What you need to know
• The ABCs of Hepatitis

Resources from the HBV and HCV Advocate:

• A Guide to Hepatitis B
• When Is Treatment [for Hepatitis B] Needed?
• Hepatitis B and Other Medical Conditions
• Hepatitis Glossary
• Links to Organizations and Resources

Resources from the Hepatitis B Foundation:

• Hepatitis B Patient Information Booklet
• ABC’s of Viral Hepatitis
• Hepatitis B Virus
• Transmission
• Symptoms
• Acute vs. Chronic Hepatitis B
• Your Liver and Its Functions
• Donating Blood
• Glossary
• Adults and HBV
• Pregnancy and HBV
• Children and HBV
• Approved Drugs for Adults
• Who Should Be Treated
• Approved Drugs for Children
• Hepatitis B Clinical Trials
• Hepatitis B Foundation Drug Watch
• Prevention Measures
• Hepatitis B Vaccine
• Hepatitis B Vaccine General Recommendations
• Vaccine Non-Responders
• Post-Exposure Treatment
• Hepatitis A Vaccine
• Hepatitis B Foundation Vaccine Watch

Guidelines

• Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents (CDC, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America)
• Hepatitis B Revaccination Effective in People with HIV (January 2008, Poz)

Selected Recent Articles

• Aflatoxin Alert: Moldy Nuts and Corn Increases Your Liver Cancer Risk 60-Times If You Have Hepatitis B.  (October 2016, Hepmag)
• Nutrition and Exercise and Hepatitis B.  (September 2016, Hepmag)
• Addition of PEG-IFN to ART does not improve hepatitis B clearance rates.  (September 2016, Healio)
• HIV Meds Haven’t Prevented End-Stage Liver Disease in Those with Hepatitis.  (September 2016, Poz)
• New Guidelines Recommend Hep B Testing Before Hep C Treatment.  (September 2016, Hepmag)
• Maine’s Heroin Crisis Leads to Major Rise in Hepatitis B.  (September 2016, Hepmag)
• People with Hepatitis B Often Lack Proper Care.  (August 2016, Hepmag)
• FDA Updates Blood Donor Screening Guidelines to Help Prevent Hepatitis B Transmission.  (August 2016, Hepmag)
• Many people in the U.S. with chronic hepatitis B not being properly monitored.  (August 2016, AIDSmap)
• Ongoing hepatitis B virus replication associated with higher mortality for people with HIV.  (August 2016, AIDSmap)
• World Health Organization Contest Seeks New Solutions for Hepatitis Testing.  (July 2016, Hepmag)
• Baraclude (Entecavir) Lowers Liver Cancer Risk in People with Hepatitis B.  (July 2016, Hepmag)
• Is a Cure for Hepatitis B Coming? Experts Say Yes.  (June 2016, Hepmag)
• HBV/HIV coinfection leads to poorer outcomes in hospitalized patients.  (June 2016, Healio)
• New HBV drugs and non-viral liver disease in HIV positive people.  (June 2016, HIV Treatment Bulletin)
• Seattle Hospital Warns 650 Dialysis Patients of Possible Hepatitis B Exposure.  (June 2016, Hepmag)
• New York City Reports Extremely High Hepatitis B Rates in Parts of Brooklyn and Queens.  (June 2016, Hepmag)
• People With Hepatitis B May Not Respond As Well to Starting HIV Treatment.  (June 2016, Hepmag)
• HIV/HBV co-infection linked to worse immune recovery and death, but tenofovir improves outcomes.  (May 2016, AIDSmap)
• High-dose HBV vaccine improves HIV patients’ long-term immune response.  (May 2016, Healio)
• New Documentary Examines Hepatitis B Among Asian Americans.  (April 2016, Hepmag)
• New Tenofovir Is As Good As, Safer Than Old Version for Hepatitis B.  (April 2016, Hepmag)
• Ending the U.S. Epidemics of Hepatitis B and Hepatitis C Is Now Feasible.  (April 2016, Hepmag); related coverage from Hepmag
• Hepatitis B Prevalence High Among Syrian Refugees in Europe.  (April 2016, Hepmag)
• Tenofovir alafenamide works well against hepatitis B with less effect on bones and kidneys.  (April 2016, AIDSmap)
• Eliminating Hepatitis B & C is Feasible, But What Will it Take to Achieve this Goal?  (April 2016, NASTAD)
• Help Stop Insurers from Over-Charging Patients for Hepatitis B Drugs on the Healthcare Marketplace.  (April 2016, Hepmag)
• ContraVir’s Hep B Treatment Beats Gilead’s New Tenofovir in Lab Tests.  (April 2016, Hepmag)
• Liver Cancer Death Rate Increasing Faster Than All Other Cancers; Implementation of Viral Hepatitis Action Plan Urgently Needed.  (March 2016, Hepmag)
• Opt-out HIV/HBV/HCV testing for patients attending emergency departments identifies significant number of new infections.  (March 2016, AIDSmap)
• CDC Statement on Liver Cancer and Hepatitis.  (March 2016, Project Inform); related coverage from Hepmag
• Institute of Medicine Expert Committee Assessing Feasibility of Viral Hepatitis Elimination Targets in the U.S.  (March 2016, Hepmag)
• HCV, HBV, alcohol use associated with ESLD in patients with HIV.  (February 2016, Healio)
• For Hep B, New Viread Proves as Effective, Safer Than Old Version.  (January 2016, Hepmag)
• Most U.S. States Not Prepared for Infectious Disease Outbreaks.  (December 2015, Hepmag)
• Less Liver Fibrosis for Coffee Drinkers with Hep B or C.  (November 2015, Hepmag)
• People With Hep B Have Raised Risk of Only Liver.  (November 2015, Hepmag)
• Tenofovir during pregnancy reduces risk of mother-to-child hepatitis B virus transmission.  (November 2015, AIDSmap)
• Promising Results for REP 2139 Treating Hep B and D Coinfection.  (November 2015, Hepmag)
• REP 2139 shows promise for people with hepatitis B and hepatitis delta co-infection.  (November 2015, AIDSmap)
• Identifying Strategies to Eliminate Perinatal Hepatitis B Transmission.  (October 2015, Hepmag)
• HIV Treatment Can Significantly Lower Risk of Hepatitis B in HIV-Positive MSM.  (October 2015, TheBodyPro.
• Successful HIV Treatment Protects Gay and Bi Men Against Hep B.  (October 2015, Hepmag)
• Origin of Hepatitis B Perhaps in the Genes of Freshwater Fish.  (October 2015, Hepmag)
• Global Trials Start For Cuba’s Promising Hepatitis B Drug.  (August 2015, Hepmag)
• Are HIV Docs Testing Enough for Hep B-Linked Liver Cancer?  (August 2015, Hepmag)
• After Hepatitis C, Gilead Seeks to Cure HIV and Hepatitis B.  (August 2015, Hepmag)
• People with HIV and hepatitis B co-infection can safely switch to simpler TAF single-tablet regimen.  (August 2015, AIDSmap)
• PrEP Is Safe for People With Hepatitis B.  (August 2015, Poz)
• People with hepatitis B can safely use Truvada PrEP for HIV prevention.  (August 2015, AIDSmap)
• Australian Hepatitis B Subtype Is 53,000 Years Old.  (August 2015, Hepmag)
• In Those With HIV, Best to Treat Hep B With Two Drugs.  (July 2015, Hepmag)
• Access to screening and treatment are key issues for hepatitis B and C and HIV/viral hepatitis co-infection.  (July 2015, AIDSmap)
• New Viral Hepatitis Numbers from the CDC.  (June 2015, Hepmag)
• Hep C Worsens Progression of Hep B Disease.  (June 2015, Hepmag)
• Hep B Vaccine Works Poorly in Those With Rheumatoid Arthritis.  (June 2015, Poz)
• Hepatitis B and C co-infection linked to worse liver fibrosis than hepatitis B alone.  (June 2015, AIDSmap)
• Early Study of Hepatitis B Immune Therapy Raises Cure Hopes.  (May 2015, Hepmag)
• Eliminating Hepatitis B in the United States – Mothers Matter!  (May 2015, Hepmag)
• New Hep B Partnership Between UPenn and Blumberg Institute.  (May 2015, Hepmag)
• Could a Cancer Drug Cure Hepatitis B?  (May 2015, Hepmag)
• Global Hep B Could Plummet With More Vaccination and Treatment.  (May 2015, Hepmag)
• Expanded vaccination and treatment could help eliminate hepatitis B worldwide.  (April 2015, AIDSmap)
• Yearly Cost to Treat Global Hepatitis B Could Be Only $36 Per Person.  (April 2015, Hepmag)
• West Virginia Faces Epidemics of Hepatitis B and Hepatitis C.  (April 2015, Hepmag)
• Babies With HBV-Positive Mothers May Have Better Immune Systems.  (April 2015, Hepmag)
• Global hepatitis B epidemic treatable at cost of just $36 per patient per year.  (April 2015, AIDSmap)
• Oral Hepatitis B Vaccine Made From GMO Corn Shows Promise.  (April 2015, Hepmag)
• World Health Organization Issues Hepatitis B Guidelines.  (March 2015, Hepmag)
• Former Gilead Executives Compete to Cure Hepatitis B.  (February 2015, Hepmag)
• Experimental siRNA therapy lowers HBsAg levels in people with hepatitis B.  (January 2015, Poz)
• Entecavir and tenofovir work well for people with drug-resistant hepatitis B virus.  (December 2014, AIDSmap)
• Viread Effectively Combats Hepatitis B for at Least 8 Years.  (December 2014, Hepmag)
• Genetically Engineered Corn Used for New Hepatitis B Vaccine.  (November 2014, Hepmag)
• Tenofovir continues to suppress hepatitis B virus for eight years.  (November 2014, AIDSmap)
• Interferon Raises Chance of HBsAg Loss in People With Hepatitis B.  (November 2014, Hepmag)
• Safety Concerns Cited Against Hepatitis B Vaccine for Infants.  (November 2014, Hepmag)
• Adding pegylated interferon to tenofovir improves odds of HBsAg loss in hepatitis B patients.  (November 2014, AIDSmap)
• Hepatitis B and NASH Next for Drug Makers After Hepatitis C Successes.  (November 2014 for Hepmag)
• Hepatitis B testing and treatment rates are low among US veterans.  (November 2014, AIDSmap)
• U.S. Vets Have Low Rates of Hep B Testing and Treatment.  (November 2014 for Hepmag)
• Priority for Liver Cancer Tests Should Go to Hep B-Positive Cirrhotics.  (October 2014, Hepmag)
• People with hepatitis B who have cirrhosis should be prioritised for liver cancer screening.  (October 2014, AIDSmap)
• WHO Report: Nearly Half of Global Hepatitis B Is in Western Pacific.  (August 2014, Hepmag)
• Isis, GSK Sign $1M Deal to Develop New Hep B Drugs.  (July 2014, Hepmag)
• Task Force Recommends Hep B Tests For Those At Risk.  (June 2014, Poz)
• Adding interferon to nucleoside antivirals may improve response for people with chronic hepatitis B.  (April 2014, AIDSmap)
• Gay Men, IDUs and People With HIV Should Test for Hep B.  (February 2014, Poz)
• China Suspends Hepatitis B Vaccines After 2 Fatalities.  (December 2013, Poz)
• Entecavir + tenofovir works well for people with hepatitis B who have had prior treatment failure.  (November 2013, AIDSmap)
• Hepatitis B treatment with entecavir or tenofovir lowers, but does not eliminate, liver cancer risk.  (November 2013, AIDSmap)
• HIV/Hep B Coinfection Responds Very Well to Viread.  (September 2013, Poz)
• Tenofovir is highly effective for HIV/HBV co-infection, meta-analysis shows.  (September 2013, AIDSmap)
• Hep B or C Coinfection Spells Worse Response to HIV Meds.  (July 2013, Poz)
• Experts discuss role of drug policy in HIV, hepatitis and TB epidemics.  (July 2013, AIDSmap)
• Hyaluronic acid levels can predict risk of serious liver events in people living with HIV and hepatitis B or C co-infection.  (June 2013, AIDSmap)
• Combo of 2 HIV Drugs Can Control Hepatitis B.  (May 2013, Poz)
• Viread and Epivir Lower Risk of Hepatitis B Infection in HIV-Positive Gay Men.  (April 2013, Poz)
• Tenofovir and 3TC prevent new hepatitis B infections in gay men living with HIV.  (April 2013, AIDSmap)
• Drinking coffee halves the risk of liver cancer.  (April 2013, AIDSmap)
• Dually active antiretroviral therapy protects against hepatitis B infection.  (March 2013, AIDSmap)
• Triple trouble: infection with hepatitis B increases risk of death for people with HIV and hepatitis C co-infection.  (February 2013, AIDSmap)
• Combining tenofovir with FTC or 3TC boosts chances of HBV suppression for people co-infected with HIV.  (February 2013, AIDSmap)
• Co-infection with hepatitis B or C is a risk factor for reduced bone mineral density among women with HIV.  (January 2013, AIDSmap)
• Hepatitis B treatment and care in the UK need to evolve to keep pace with the global epidemic.  (January 2013, AIDSmap)